Xenon Pharmaceuticals Inc. · NASDAQ:XENE
BlackRock, Inc. reported a 6.20% stake in Xenon Pharmaceuticals Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 6.20% stake in Xenon Pharmaceuticals Inc., 4,757,709 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G).
- Stake
- 6.20%
- Shares
- 4,757,709
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.20% | 4,757,709 |